Detection by monoclonal antibodies of the Wilms' tumor (WT1) nuclear protein in patients with acute leukemia
Open Access
- 4 March 1997
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 70 (5) , 518-523
- https://doi.org/10.1002/(sici)1097-0215(19970304)70:5<518::aid-ijc5>3.0.co;2-0
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The Wilms' tumor gene is frequently expressed in acute myeloblastic leukemias and may provide a marker for residual blast cells detectable by PCRAnnals of Oncology, 1995
- G1 phase arrest induced by Wilms tumor protein WT1 is abrogated by cyclin/CDK complexes.Proceedings of the National Academy of Sciences, 1995
- WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemiaBlood, 1994
- The role of WT1 in Wilms tumorigenesisThe FASEB Journal, 1993
- The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryoMechanisms of Development, 1993
- Repression of the Insulin-Like Growth Factor II Gene by the Wilms Tumor Suppressor WT1Science, 1992
- Modulation of DNA Binding Specificity by Alternative Splicing of the Wilms Tumor wt1 Gene TranscriptScience, 1992
- Alternative splicing and genomic structure of the Wilms tumor gene WT1.Proceedings of the National Academy of Sciences, 1991
- Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumpingNature, 1990
- Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locusCell, 1990